Regulatory Approval

The AMA's approval of Category I codes for single-lead neurostimulators marks a massive operational shift for sleep apnea care and clinical adoption.

As the federal government transitions to automated security validation, a new pilot proves that continuous compliance is the digital backbone of the future.

BioCardia’s revised FDA submission for its Helix catheter could set a new regulatory standard and unlock lucrative biopharma partnerships.

The NHS rollout of Tryngolza offers a monthly RNA-targeted lifeline for FCS patients, proving the practical value of execution in genetic lipid disorders.

A proposed year-round sightseeing tram near Glacier National Park tests the balance between accessible tourism, economic growth, and wilderness preservation.

As default natural gas rates jump nearly 30% for October, Albertans face a collision between global energy markets and the reality of regional utility divides.

Ceribell's latest FDA clearance for age-agnostic, AI-driven EEG trending is democratizing brain monitoring and redefining the medtech SaaS playbook.

Gardner Medical Instruments just secured FDA Class I registration for a system that maintains continuous ventilation during intubation. Will it change the standard of care?

Ascribe Bioscience has secured the world’s first regulatory approval for an ascaroside biofungicide. Here is why the Cornell spinout bypassed the US for Brazil.

A new blood test promises to predict scoliosis progression with perfect accuracy. But do the corporate ties and statistical claims hold up to scrutiny?

With a $22.3 million NIH renewal, Florida's premier Alzheimer's consortium is pioneering non-invasive AI imaging, blending academic rigor with medtech agility.

Azurity's newly approved liquid lamotrigine isn't just a convenience—it's a critical safety measure for pediatric epilepsy and bipolar patients facing high risks.

Lupin’s tentative FDA approval for a liquid alternative to Eliquis highlights a strategic pivot toward value-added formulations and onshore manufacturing.

As St. Luke's Anderson Campus achieves Level I trauma accreditation, the strategic move reshapes the Lehigh Valley healthcare duopoly and emergency care.

As global myopia rates surge, the FDA faces a high-stakes showdown over Sydnexis's SYD-101. The outcome will redefine pediatric eye care and supply chains.

Profusa's injectable biosensor cleared a major EU regulatory hurdle, but severe cash constraints and a massive pivot raise existential questions for the company.

KVK-Tech announced a flawless FDA inspection this week. But behind the press release lies a complex story of federal monitors and generic drug economics.

As US policies freeze out Chinese biopharma, Altruist Biologics' flawless EMA audit reveals a pragmatic Europe prioritizing patient access over politics.

Smith+Nephew's newly FDA-cleared LANDMARK knee system pairs 3D-printed implants with compact robotics to target the booming outpatient surgery market.

As Cygnus Metals and CAML finalize their merger, a digital portal update in Kazakhstan shows how administrative red tape can pause global mining consolidation.